Physician profile
Rammohan Marla
NPI 1063583359
$90,309.94
in general payments reported to CMS, 2019-2025
47 companies · $3,135 in 2025
The $3,135 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $29K · 2021: $32K · 2022: $8,286 · 2023: $6,507 · 2024: $11K · 2025: $3,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,327 · Food and Beverage: $7,028 · Education: $4,000 · Consulting Fee: $525 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,327.00 |
| Food and Beverage | $7,028.32 |
| Education | $4,000.00 |
| Consulting Fee | $525.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $73,851.54 | 2019-2024 | Da Vinci Surgical System, Davinci Xi |
| Medtronic, INC. | $5,529.99 | 2021-2025 | Signia, Ligasure, Illumisite |
| Davol INC. | $2,156.51 | 2021-2025 | Progel Applicator Spray Tips, Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $2,054.39 | 2021-2024 | Advantagerib |
| Atricure, INC. | $2,006.84 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $779.46 | 2019-2025 | Imfinzi, Lynparza, Fasenra |
| Covidien LP | $582.55 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $512.07 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Ethicon INC. | $325.22 | 2021 | |
| Electromed, INC. | $228.26 | 2022-2024 | Smartvest |
| Pfizer INC. | $188.12 | 2020-2024 | |
| Amgen INC. | $185.45 | 2023-2024 | Tezspire |
| Grifols USA, LLC | $181.47 | 2022-2024 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $140.48 | 2022-2025 | Libtayo, Dupixent |
| Relievant Medsystems, INC. | $136.20 | 2019 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dova Pharmaceuticals | $124.99 | 2020 | |
| Pulmonx Corporation | $119.21 | 2022 | |
| Veran Medical Technologies, INC. | $108.11 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $82.78 | 2023-2024 | Xpovio |
| Philips North America LLC | $74.51 | 2019-2024 | (7999) Src Undivided |
| Actelion Pharmaceuticals US, INC. | $68.48 | 2022-2024 | Opsumit |
| Ethicon US, LLC | $67.61 | 2021-2022 | |
| Endologix LLC | $65.55 | 2019 | |
| Becton, Dickinson and Company | $61.17 | 2023 | Progel Applicator Spray Tips |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.91 | 2023-2025 | Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $52.77 | 2024-2025 | Fruzaqla, Glassia |
| Jazz Pharmaceuticals INC. | $51.24 | 2023 | |
| Getinge USA Sales, LLC | $50.15 | 2021 | |
| Seagen INC. | $49.85 | 2023 | Adcetris, Tukysa |
| Janssen Pharmaceuticals, INC | $49.70 | 2019 | |
| Blueprint Medicines Corporation | $39.04 | 2023-2024 | Ayvakit, Gavreto |
| W. L. Gore & Associates, INC. | $32.98 | 2019 | |
| Caris Mpi, INC. | $29.02 | 2025 | Mi Cancer Seek |
| Optinose US, INC. | $27.29 | 2024 | |
| Insmed, INC. | $26.83 | 2023 | Arikayce |
| United Therapeutics Corporation | $24.86 | 2023 | Tyvaso |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.50 | 2023 | Lifevest |
| Genentech USA, INC. | $21.31 | 2023 | Gavreto, Alecensa, Rozlytrek |
| Medtronic Vascular, INC. | $19.54 | 2020 | |
| Baxter Healthcare | $17.93 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Paratek Pharmaceuticals, INC. | $17.44 | 2023 | Nuzyra |
| Sobi, INC | $17.06 | 2025 | |
| Genentech, INC. | $16.97 | 2023 | Tecentriq |
| Bard Peripheral Vascular, INC. | $16.15 | 2019 | |
| Koya Medical, INC. | $14.70 | 2025 | Koya Medical, Dayspring |
| Advanced Oxygen Therapy INC. | $12.00 | 2025 | Topical Oxygen Chamber For Extremities |
| Inogen, INC. | $8.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rammohan Marla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.